Magnesium L-Threonate
Magnesium L-Threonate is a novel form of magnesium developed at MIT specifically for its ability to cross the blood-brain barrier and increase brain magnesium levels — something other forms (glycinate, citrate, oxide) do poorly. Animal studies showed significant improvements in synaptic density, LTP (long-term potentiation), working memory, and cognitive aging reversal. Human RCTs in older adults with cognitive impairment showed significant improvements in executive function and attention. Distinct from magnesium glycinate: MgT for brain, glycinate for sleep/anxiety/muscle. Often combined.
Evidence
No score yet
Safety
Unknown safety profile
Clinical Status
No formal phase listed
Research Sync
Not synced yet
Dosing
Pharmacology
Evidence Score
Plain-English Snapshot
Magnesium L-Threonate is currently categorized as a vitamin mineral compound.
Evidence scoring has not been fully computed yet, so interpret this profile as preliminary.
Safety scoring is incomplete. Start conservatively and monitor carefully.
Core mechanism
Uniquely elevates cerebrospinal fluid and synaptic magnesium; increases synaptic density via NMDA receptor modulation; activates PKA/PKC signaling for synaptic plasticity
Practical Context
Strongest current signals
No indexed study summaries yet.